000 | 01940 a2200565 4500 | ||
---|---|---|---|
005 | 20250518082244.0 | ||
264 | 0 | _c20200727 | |
008 | 202007s 0 0 eng d | ||
022 | _a2574-3805 | ||
024 | 7 |
_a10.1001/jamanetworkopen.2019.18554 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNeugebauer, Romain | |
245 | 0 | 0 |
_aComparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins. _h[electronic resource] |
260 |
_bJAMA network open _c01 2020 |
||
300 |
_ae1918554 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiabetic Cardiomyopathies _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
650 | 0 | 4 |
_aInsulin, Regular, Human _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xetiology |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStroke _xetiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSchroeder, Emily B | |
700 | 1 | _aReynolds, Kristi | |
700 | 1 | _aSchmittdiel, Julie A | |
700 | 1 | _aLoes, Linda | |
700 | 1 | _aDyer, Wendy | |
700 | 1 | _aDesai, Jay R | |
700 | 1 | _aVazquez-Benitez, Gabriela | |
700 | 1 | _aHo, P Michael | |
700 | 1 | _aAnderson, Jeff P | |
700 | 1 | _aPimentel, Noel | |
700 | 1 | _aO'Connor, Patrick J | |
773 | 0 |
_tJAMA network open _gvol. 3 _gno. 1 _gp. e1918554 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamanetworkopen.2019.18554 _zAvailable from publisher's website |
999 |
_c30556149 _d30556149 |